Sukonthasarn, Apichard

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., et al. (2019) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 315

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., Landmesser, U., López-Jaramillo, P., Manvelian, G., Pordy, R., et al. (2021) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 150

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström, E., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Danchin, N., Diaz, R., Goodman, S. G., Harrington, R. A., Jukema, J. W., et al. (2022) · Circulation

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 118

2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network

Kario, K., Park, S., Chia, Y., Sukonthasarn, A., Turana, Y., Shin, J., Chen, C., Buranakitjaroen, P., Divinagracia, R., Nailes, J., et al. (2020) · The Journal of Clinical Hypertension

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 76

Home blood pressure-centered approach – from digital health to medical practice: HOPE Asia Network consensus statement 2023

Kario, K., Tomitani, N., Wang, T.-D., Park, S., Li, Y., Shin, J., Tsoi, K., Chen, C.-H., Cheng, H.-M., Siddique, S., et al. (2023) · Hypertension Research

Blood Pressure and Hypertension StudiesNon-Invasive Vital Sign Monitoring

Cited by 40